Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : DUSA (DUSA) Pharmaceutical -- Ignore unavailable to you. Want to Upgrade?

To: Ron Harvey who wrote (29)	5/28/1998 10:50:00 PM
From: Darryl Wagner	Respond to of 101

Unfortunately, I bought at just under 11 recently. I agree the selloff was overdone for the news. I think this price is very attractive and don't expect this thing to be under 10 for long. Seriously considering averaging down right now.

To: Ron Harvey who wrote (29)	5/28/1998 11:47:00 PM
From: Jeremy Niles Harris	Respond to of 101

It would appear that Dusa's expectations were unrealistic or the big pharma was hoping for a steal. Hopefully Dusa's management will learn from this experience and either negotiate more realistically and more on the qt. Having said this, nothing has changed that merits this overreaction .